Qasim Khan


Contact Information

University Hospital, 339 Windermere Road, London, Ontario N6A 5A5, C4-211
Tel: 519.685.8500 ext. 32913
Fax: 519.663-3549

Research Interests/Specialization

Optimization and management of pre- and post-liver transplant cardiometabolic conditions, Non-alcoholic Fatty Liver Disease (NAFLD) and Portal Hypertension

Dr. Khan is an Assistant Professor of Medicine in the Division of Gastroenterology at the University of Western Ontario, specializing in Advanced and Transplant Hepatology. He is also an Associate Scientist at the Lawson Health Research Institute and a member of the Program of Experimental Medicine. 

After initiating undergraduate studies at the University of Toronto, he completed his medical training with distinction at the King Edward Medical University in Lahore, Pakistan. He subsequently pursued post-graduate medical training in the United States where he completed his Internal Medicine residency and Gastroenterology fellowship at the University of Chicago – NorthShore University Health System. Given his clinical and research interests in liver disease, he pursued advanced fellowship training in Transplant Hepatology at the Mayo Clinic in Rochester, MN.

Dr. Khan’s areas of research interest include: (1) Optimization and Management of Pre- and Post-liver transplant cardiometabolic conditions, i.e. post-transplant weight gain, diabetes mellitus, metabolic syndrome and allograft steatosis; (2) Non-alcoholic Fatty Liver Disease (NAFLD); and (3) Portal Hypertension. His previous research and quality improvement work has focused on utilization of electronic medical records (EMR) systems for non-invasive identification of fibrosis in patients with hepatitis C and NAFLD and subsequently facilitating improved screening, risk stratification and referrals for these patients. 

He is a Steering Committee member of the Clinical Practice Special Interest Group of the American Association for the Study of Liver Diseases (AASLD) and an active member of the European Association for the Study of the Liver (EASL), American Gastroenterological Association (AGA) and the American College of Gastroenterology (ACG).

Selected Publications

Khan, Mohammad Qasim, et al. "Pseudo‐Wilsonian Crisis in a ATP7B Heterozygote." Liver Transplantation 28.1 (2022): 131-133.

Richardson, Brooks, Khan, Mohammad Qasim et al. "Personalizing Diabetes Management in Liver Transplant Recipients: The New Era for Optimizing Risk Management." Hepatology Communications (2021).

Fimmel, Claus J., Khan, Mohammad Qasim et al. "Sustained and cumulative impact of an electronic medical record‐based alert on a hepatitis C birth cohort screening program." Journal of Viral Hepatitis (2021).

Khan, Mohammad Qasim, et al. "Effect of a Best Practice Alert on Birth-Cohort Screening for Hepatitis C Virus." Clinical and Translational Gastroenterology 12.1 (2021).

Belopolsky, Yuliya, Khan, Mohammad Qasim, et al. "Ketogenic, hypocaloric diet improves nonalcoholic steatohepatitis." Journal of Translational Internal Medicine 8.1 (2020): 26-31.

Yeboah-Korang, Amoah, Beig, Muhammad Imran, Khan, Mohammad Qasim, Goldstein, Jay et al. "Hepatitis C screening in commercially insured US birth-cohort patients: Factors associated with testing and effect of an EMR-based screening alert." Journal of Translational Internal Medicine 6.2 (2018):82.

Khan, Mohammad Qasim et al. "Utility of electronic medical record-based fibrosis scores in predicting advanced cirrhosis in patients with hepatitis C virus infection." Journal of Translational Internal Medicine 5.1 (2017): 43-48.

Anand, Vijay, Hyun, Christian, Khan, Mohammad Qasim et al. "Identification and Fibrosis Staging of Hepatitis C Patients Using the Electronic Medical Record System." Journal of clinical gastroenterology 50.8 (2016): 664-669.